Stock Events

Stock Events

Relmada Therapeutics (4E2.F) Q4 2025 Earnings

13NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-0.62

-0.5

-0.38

-0.26

Details

Expected EPS

-0.36476958000000004

Actual EPS

-0.25797

Surprise EPS

0.11

Surprise Percent

+29.28%

Description

Relmada Therapeutics (4E2.F) has reported earnings of -0.25797 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.